|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07D 487/14 | |
| C07D 491/14 | |||
| C07D 495/14 | |||
| C07D 498/14 | |||
| A61K 31/519 | |||
| A61P 35/00 |
| (11) | Patento numeris | 2813506 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 14177962.9 |
| Europos patento paraiškos padavimo data | 2011-12-15 | |
| (97) | Europos patento paraiškos paskelbimo data | 2014-12-17 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2016-05-25 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (30) | Numeris | Data | Šalis |
| 423694 P | 2010-12-16 | US |
| (72) |
Dotson, Jennafer, US
Heald, Robert Andrew, GB
Heffron, Timothy, US
Jones, Graham Elgin, GB
Krintel, Sussie Lerche, GB
McLean, Neville James, GB
Ndubaku, Chudi, US
Olivero, Alan G., US
Salphati, Laurent, US
Wang, Lan, US
Wei, BinQing, US
|
| (73) |
F. Hoffmann-La Roche AG,
Grenzacherstrasse 124, 4070 Basel,
CH
|
| (54) | Tricyclic PI3K inhibitor compounds and methods of use |
| Tricyclic PI3K inhibitor compounds and methods of use |